- Novasep Process Solutions continues independently in its legacy market
- Novasep and PharmaZell become one group
- Thermo Fisher Scientific acquires Henogen S.A., Novasep’s viral vector manufacturing business in Belgium
- Partnership with AstraZeneca to produce COVID-19 vaccine
- Investment of €6.5 million to expand capacity and increase flexibility in an API manufacturing workshop at its Chasse-sur-Rhône site, France
- Novasep opens Senefill, a unit dedicated to Fill & Finish aseptic commercial operations in Seneffe, Belgium
- Novasep opens a new Viral Vector Commercial Production Facility in Seneffe, Belgium (€27m investment)
- Novasep opens the world’s largest chromatography plant in the pharmaceutical industry to produce omega-3 fatty acids.
- Opening of the Sales Office of Bangkok, in Thailand
- Move of Group Management Center from Pompey to Lyon, in the Gerland Biodistrict
- Opening of the Sales office of Bangalore, in India
- Appointment of Michel Spagnol as CEO, then he was appointed as Chairman of the Administrative Board in March 2014
- Acquisition of HENOGEN: cGMP upstream and downstream bioproduction, specialized in virus production and viral vectors.
- €9M investment in a large scale biocatalysis / purification workshop in CSR
2007 - 2008
- Scale-up of new chemical technologies : Ozonolysis, Cyclopropanation, Carbonylation, O2 oxidation
- Acquisition of PHARMACHEM: expansion of API manufacturing in North America
- Development of BioSC, continuous chromatography technology for biomolecules purification
- Industrial diborane and diazomethane chemistry
- Acquisition of DNES Dynamit Nobel Leverkusen's site and Finorga (sites of Chasse-sur-Rhône and Mourenx)
- Creation of Novasep Asia
- Acquisition of APPLEXION and ORELIS: World leadership in purification processes for agro-bio-industrial industries
- Acquisition of SERIPHARM, located in Le Mans, France: Global manufacturing leader of Highly Potent APIs
- Development of a global synthesis and purification CMO offer
- Opening of the Pompey site, in France
- Creation of Novasep, Inc in the US: Local presence on world major pharmaceutical market
- First industrial pharma separation on an industrial scale by continuous chromatography
- Creation of Novasep by Roger-Marc Nicoud: Niche expertise in continuous purification technologies
Curious to know more about what we are currently working on?
Check out our media & events page!